Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: An observational prospective cohort study

PLoS Medicine

Volumn 7, Issue 10, 2010, Pages

  Cortina Borja, Mario ^a   Tan, Hooi Kuan ^a   Wallon, Martine ^b   Paul, Malgorzata ^c   Prusa, Andrea ^d   Buffolano, Wilma ^e   Malm, Gunilla ^f   Salt, Alison ^a   Freeman, Katherine ^g   Petersen, Eskild ^h   Gilbert, Ruth E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CROIX ROUSSE HOSPITAL   (France)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN;

ARTICLE; BRAIN DAMAGE; CLINICAL TRIAL; COHORT ANALYSIS; CONGENITAL TOXOPLASMOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EUROPE; FEMALE; FETUS; FETUS DEVELOPMENT; GESTATIONAL AGE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MONOTHERAPY; MULTICENTER STUDY; NEUROLOGICAL COMPLICATION; NEWBORN MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POSTNATAL CARE; PREGNANCY TERMINATION; PRENATAL CARE; PRENATAL SCREENING; RISK REDUCTION; SEROCONVERSION; VISUAL IMPAIRMENT;

AUSTRIA; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; ITALY; NERVOUS SYSTEM DISEASES; OBSERVATION; PREGNANCY; PRENATAL CARE; TOXOPLASMOSIS, CONGENITAL;

EID: 78149373357     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000351     Document Type: Article

References (31)

1. Remington JS, McLeod R, Thulliez P, Desmonts G (2006) Toxoplasmosis. Remington JS, Klein J, Wilson CB, Baker CJ, eds. Infectious disease of the fetus and newborn infant. Philadelphia: Elsevier Saunders. pp 947-1092.
2. Ferreira-da-Silva MF, Takacs AC, Barbosa HS, Gross U, Luder CG (2009) Primary skeletal muscle cells trigger spontaneous Toxoplasma gondii tachyzoite-to-bradyzoite conversion at higher rates than fibroblasts. Int J Med Microbiol 299: 381-388.
3. The SYROCOT Study Group, Thiebaut R, Leproust S, Chene G, Gilbert RE (2007) Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 369: 115-122.
4. Gilbert R, Gras L (2003) Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 110: 112- 120.
5. Freeman K, Tan HK, Prusa A, Petersen E, Buffolano W, et al. (2008) Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Pediatrics 121: e1215-e1222.
6. Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, et al. (2005) Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centers. Acta Paediatrica Scandinavia 94: 1721-1731.
7. Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, et al. (1999) Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 353: 1834-1837.
8. Paul M, Petersen E, Szczapa J (2001) Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznan region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies. J Clin Microbiol 39: 1912-1916.
9. Tan HK, Schmidt D, Stanford M, Tear-Fahnehjelm K, Ferret N, et al. (2007) Risk of visual impairment in children with congenital toxoplasmic retinocho-roiditis. Am J Ophthalmol 144: 648-653.
10. Berrebi A, Kobuch WE, Bessieres MH, Bloom MC, Rolland M, et al. (1994) Termination of pregnancy for maternal toxoplasmosis. Lancet 344: 36-39.
11. Gay-Andrieu F, Marty P, Pialat J, Sournies G, Drier dL, et al. (2003) Fetal toxoplasmosis and negative amniocentesis: necessity of an ultrasound follow-up. Prenat Diagn 23: 558-560.
12. Berrebi A, Bardou M, Bessieres MH, Nowakowska D, Castagno R, et al. (2007) Outcome for children infected with congenital toxoplasmosis in the first trimester and with normal ultrasound findings: a study of 36 cases. Eur J Obstet Gynecol Reprod Biol 135: 53-57.
13. Gomez G, Espinal A, Lagakos W (2003) Inference for a linear regression model with an interval-censored covariate. Stat Med 22: 409-425.
14. Dunn D, Wallon M, Peyron F, Petersen E, Peckham CS, et al. (1999) Mother to child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353: 1829-1833.
15. Gilbert RE, Gras L, Wallon M, Peyron F, Ades AE, et al. (2001) Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: a cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol 30: 1303-1308.
16. Gras L, Gilbert RE, Ades AE, Dunn DT (2001) Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol 30: 1309-1330.
17. Wallon M, Dunn D, Slimani D, Girault V, Gay-Andrieu F, et al. (1999) Diagnosis of congenital toxoplasmosis at birth: what is the value of testing for IgM and IgA? Eur J Pediatr 158: 645-649.
18. Gilbert RE, Thalib L, Tan HK, Paul M, Wallon M, et al. (2007) Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen 14: 8-13.
19. Heineman KR, Hadders-Algra M (2008) Evaluation of neuromotor function in infancy-A systematic review of available methods. J Dev Behav Pediatr 29: 315-323.
20. Brooks S, Gelman A (1998) General methods for monitoring convergence of iterative simulations. J Comput Graph Stat 7: 434-455.
21. Spiegelhalter D, Best N, Carlin B, van der Linde A (2002) Bayesian measures of complexity and fit. J R Stat Soc Series B Stat Methodol. pp 583-639.
22. Paul M, Petersen E, Pawlowski ZS, Szczapa J (2000) Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J 19: 30-36.
23. Evengard B, Petterson K, Engman M-L, Wiklund S, Ivarsson SA, et al. (2001) Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 127: 121-127.
24. Daveluy A, Haramburu F, Bricout H, Costanzo MC, Fourrier A, et al. (2005) Review of data related to side effects of drugs used in congenital toxoplasmosis. Panel 2. [Unpublished report]. Bordeaux (France): The Eurotoxo Group. Available at http://eurotoxo.isped.u-bordeaux2.fr/WWW_PUBLIC/DOC/Side_effects_main_dr ugs_v3.pdf. Accessed 10 September 2010.
25. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, et al. (1999) Treatment of toxoplasmosis during pregnancy: a multicentre study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 180: 410-415.
26. Gilbert RE, Peckham CS (2002) Congenital toxoplasmosis in the United Kingdom: to screen or not to screen? J Med Screen 9: 135-141.
27. Hernan MA, Hernandez-Diaz S, Werler MM, Mitchell AA (2002) Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 155: 176-184.
28. Freeman K, Oakley L, Pollak A, Buffolano W, Petersen E, et al. (2004) Congenital toxoplasmosis and preterm birth, low birth weight, and small for gestational age birth. BJOG 112: 31-37.
29. Gras L, Gilbert RE, Wallon M, Peyron F, Cortina-Borja M (2004) Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect 132: 541-548.
30. Levine D, Feldman HA, Tannus JF, Estroff JA, Magnino M, et al. (2008) Frequency and cause of disagreements in diagnoses for fetuses referred for ventriculomegaly. Radiology 247: 516-527.
31. Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LM, Tan HK, et al. (2008) Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis 2: e277. doi:10.1371/journal.pntd.0000277.